Hubilu Venture Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Hubilu Venture Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2015 to Q3 2024.
  • Hubilu Venture Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $66.5K, a 7.22% increase year-over-year.
  • Hubilu Venture Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$331K, a 1037% decline year-over-year.
  • Hubilu Venture Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$275K, a 87.7% decline from 2022.
  • Hubilu Venture Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$147K, a 442% decline from 2021.
  • Hubilu Venture Corp annual Net Income (Loss) Attributable to Parent for 2021 was $42.9K.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$331K $66.5K +$4.48K +7.22% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$336K -$57.5K -$59.2K -3610% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$277K -$5.22K -$1.49K -39.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$275K -$335K -$311K -1264% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $35.4K $62K +$104K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$68.9K $1.64K +$33.7K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$103K -$3.73K +$44.1K +92.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$147K -$24.6K +$60.7K +71.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$207K -$42.3K -$138K -144% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$69K -$32K -$13K -68.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$56K -$47.8K -$98.9K -194% Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-09
Q4 2021 $42.9K -$85.3K -$38.4K -81.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-05-02
Q3 2021 $81.3K $96.1K +$98.7K Jul 1, 2021 Sep 30, 2021 10-Q 2023-01-11
Q2 2021 -$17.4K -$19K -$12.7K -202% Apr 1, 2021 Jun 30, 2021 10-Q 2022-09-12
Q1 2021 -$4.7K $51K +$174K Jan 1, 2021 Mar 31, 2021 10-Q 2022-06-06
Q4 2020 -$179K -$46.9K +$174K +78.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$353K -$2.55K +$39.7K +94% Jul 1, 2020 Sep 30, 2020 10-Q 2022-01-07
Q2 2020 -$393K -$6.29K +$90.5K +93.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 -$483K -$123K +$94K +43.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-09-16
Q4 2019 -$577K -$221K +$562K +71.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-08-09
Q3 2019 -$1.14M -$42.2K -$103K -170% Jul 1, 2019 Sep 30, 2019 10-Q 2021-04-21
Q2 2019 -$1.04M -$96.8K -$161K -250% Apr 1, 2019 Jun 30, 2019 10-Q 2020-12-30
Q1 2019 -$876K -$217K -$505K -175% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$370K -$784K -$741K -1742% Oct 1, 2018 Dec 31, 2018 10-K 2020-07-17
Q3 2018 $371K $60.4K +$128K Jul 1, 2018 Sep 30, 2018 10-Q 2020-01-02
Q2 2018 $242K $64.4K +$130K Apr 1, 2018 Jun 30, 2018 10-Q 2019-12-10
Q1 2018 $112K $288K +$350K Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-18
Q4 2017 -$238K -$42.5K +$25.6K +37.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-08-30
Q3 2017 -$263K -$68K +$7.4K +9.82% Jul 1, 2017 Sep 30, 2017 10-Q 2018-12-06
Q2 2017 -$270K -$65.3K -$21.8K -50.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 -$249K -$61.7K -$36.1K -141% Jan 1, 2017 Mar 31, 2017 10-Q 2018-08-01
Q4 2016 -$213K -$68.1K Oct 1, 2016 Dec 31, 2016 10-K/A 2018-06-07
Q3 2016 -$75.4K -$60.8K -417% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-17
Q2 2016 -$43.5K -$7.76K -21.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$25.6K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-16
Q3 2015 -$14.6K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-21
Q2 2015 -$35.7K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.